Nymox Pharmaceutical
NYMX
#9956
Rank
A$29.65 M
Marketcap
Country
$0.32
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.35 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$10.61 Million, an increase over its 2021 earnings that were of -A$20.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

20002005201020152020-$50M-$40M-$30M-$20M-$10M$10M0companiesmarketcap.com

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.35 Million-68.45%
2022 -A$10.61 Million-47.71%
2021 -A$20.29 Million6.61%
2020 -A$19.03 Million-10.91%
2019 -A$21.36 Million24.24%
2018 -A$17.19 Million-20.03%
2017 -A$21.49 Million2.71%
2016 -A$20.93 Million-63.86%
2015 -A$57.9 Million674.44%
2014 -A$7.48 Million-6.11%
2013 -A$7.97 Million-35.66%
2012 -A$12.38 Million-20.76%
2011 -A$15.62 Million38.33%
2010 -A$11.3 Million35.59%
2009 -A$8.33 Million11.8%
2008 -A$7.45 Million-12.94%
2007 -A$8.56 Million8.85%
2006 -A$7.86 Million36.5%
2005 -A$5.76 Million-4.4%
2004 -A$6.03 Million-14.58%
2003 -A$7.06 Million
2001 -A$5.18 Million-20.54%
2000 -A$6.52 Million21.72%
1999 -A$5.35 Million-25.56%
1998 -A$7.19 Million101.3%
1997 -A$3.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$11.01 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.28 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.80 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.49 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.89 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA